Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 8
2004 9
2005 9
2006 6
2007 6
2008 1
2009 9
2010 15
2011 8
2012 3
2013 6
2014 10
2015 4
2016 1
2017 2
2018 8
2019 5
2020 3
2021 7
2022 9
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy.
Ruzzi F, Semprini MS, Scalambra L, Palladini A, Angelicola S, Cappello C, Pittino OM, Nanni P, Lollini PL. Ruzzi F, et al. Among authors: lollini pl. Int J Mol Sci. 2023 Aug 19;24(16):12963. doi: 10.3390/ijms241612963. Int J Mol Sci. 2023. PMID: 37629147 Free PMC article. Review.
IL-1 Family Members in Bone Sarcomas.
Landuzzi L, Ruzzi F, Pellegrini E, Lollini PL, Scotlandi K, Manara MC. Landuzzi L, et al. Among authors: lollini pl. Cells. 2024 Jan 25;13(3):233. doi: 10.3390/cells13030233. Cells. 2024. PMID: 38334625 Free PMC article. Review.
IFN-γ and CD38 in Hyperprogressive Cancer Development.
Angelicola S, Ruzzi F, Landuzzi L, Scalambra L, Gelsomino F, Ardizzoni A, Nanni P, Lollini PL, Palladini A. Angelicola S, et al. Among authors: lollini pl. Cancers (Basel). 2021 Jan 15;13(2):309. doi: 10.3390/cancers13020309. Cancers (Basel). 2021. PMID: 33467713 Free PMC article. Review.
Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma.
Chiarini F, Paganelli F, Balestra T, Capanni C, Fazio A, Manara MC, Landuzzi L, Petrini S, Evangelisti C, Lollini PL, Martelli AM, Lattanzi G, Scotlandi K. Chiarini F, et al. Among authors: lollini pl. Cell Death Dis. 2022 Apr 14;13(4):346. doi: 10.1038/s41419-022-04729-5. Cell Death Dis. 2022. PMID: 35422060 Free PMC article.
The Promise of Preventive Cancer Vaccines.
Lollini PL, Cavallo F, Nanni P, Quaglino E. Lollini PL, et al. Vaccines (Basel). 2015 Jun 17;3(2):467-89. doi: 10.3390/vaccines3020467. Vaccines (Basel). 2015. PMID: 26343198 Free PMC article. Review.
Preclinical vaccines against mammary carcinoma.
Lollini PL, Cavallo F, De Giovanni C, Nanni P. Lollini PL, et al. Expert Rev Vaccines. 2013 Dec;12(12):1449-63. doi: 10.1586/14760584.2013.845530. Expert Rev Vaccines. 2013. PMID: 24195482 Free article. Review.
Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma.
Carrabotta M, Laginestra MA, Durante G, Mancarella C, Landuzzi L, Parra A, Ruzzi F, Toracchio L, De Feo A, Giusti V, Pasello M, Righi A, Lollini PL, Palmerini E, Donati DM, Manara MC, Scotlandi K. Carrabotta M, et al. Among authors: lollini pl. Cancer Res. 2022 Feb 15;82(4):708-720. doi: 10.1158/0008-5472.CAN-21-1222. Cancer Res. 2022. PMID: 34903601 Free PMC article.
Oncolytic herpes virus retargeted to HER-2.
Lollini PL, Menotti L, De Giovanni C, Campadelli-Fiume G, Nanni P. Lollini PL, et al. Cell Cycle. 2009 Sep 15;8(18):2859-60. doi: 10.4161/cc.8.18.9368. Epub 2009 Sep 26. Cell Cycle. 2009. PMID: 19729994 No abstract available.
Cancer immunoprevention.
Lollini PL, De Giovanni C, Pannellini T, Cavallo F, Forni G, Nanni P. Lollini PL, et al. Future Oncol. 2005 Feb;1(1):57-66. doi: 10.1517/14796694.1.1.57. Future Oncol. 2005. PMID: 16555976 Review.
Immunization in tumor prevention.
Forni G, Curcio C, Spadaro M, Iliffe J, Quaglino E, Di Carlo E, Musiani P, Lollini PL. Forni G, et al. Among authors: lollini pl. Int Immunopharmacol. 2003 Aug;3(8):1151-8. doi: 10.1016/S1567-5769(03)00026-2. Int Immunopharmacol. 2003. PMID: 12860170 Review.
131 results